Sign in
4/A

Changes in Ownership

C4 Therapeutics, Inc. Filed Acc 0001209191-22-036718

Chief Legal Officer gave up 1,102 shares (to pay taxes)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Siegel Jolie Chief Legal Officer 2022-05-26 Shares withheld for taxes −1,102 $7.01 $7,725 2,648 D
Loading xslF345X03/doc4a.xml…